Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 226 AL 240

Radiolabeled peptides for Alzheimer's diagnostic imaging: mini review

Barrios-Lopez B, Raki M, Bergström K.

Curr Radiopharm. 2013 Dec;6(4):181-91. doi: 10.2174/1874471006666131126222835.

Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials

Molino I, Colucci L, Fasanaro AM, Traini E, Amenta F.

ScientificWorldJournal. 2013 Oct 29;2013:925702. doi: 10.1155/2013/925702. eCollection 2013.

[Experience of a care pathway for psychological and behavioral symptoms of dementia]

Delphin-Combe F, Martin-Gaujard G, Roubaud C, Fortin ME, Husson F, Rouch I, Krolak-Salmon P.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(4):416-22. doi: 10.1684/pnv.2013.0428.

[A case report of early-onset Alzheimer's disease with multiple psychotic symptoms, finally diagnosed as APPV717I mutation by genetic testing]

Ishimaru T, Ochi S, Matsumoto T, Yoshida T, Abe M, Toyota Y, Fukuhara R, Tanimukai S, Ueno S.

Seishin Shinkeigaku Zasshi. 2013;115(10):1042-50.

[Pharmacological and non-pharmacological treatment of Alzheimer's dementia]

Wallesch CW.

MMW Fortschr Med. 2013 May 2;155(8):60-2. doi: 10.1007/s15006-013-0643-4.

Effects of isoflurane-induced anaesthesia on cognitive performance in a mouse model of Alzheimer's disease: A randomised trial in transgenic APP23 mice

Eckel B, Ohl F, Starker L, Rammes G, Bogdanski R, Kochs E, Blobner M.

Eur J Anaesthesiol. 2013 Oct;30(10):605-11. doi: 10.1097/EJA.0b013e32835b824b.

Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies

Ballard C, Francis P, Corbett A.

Int Psychogeriatr. 2013 May;25(5):687-9. doi: 10.1017/S1041610213000033. Epub 2013 Jan 25.

Alzheimer's disease and diabetes: new insights and unifying therapies

Vignini A, Giulietti A, Nanetti L, Raffaelli F, Giusti L, Mazzanti L, Provinciali L.

Curr Diabetes Rev. 2013 May;9(3):218-27. doi: 10.2174/1573399811309030003.

Two cases of loss of consciousness after long-term memantine treatment

Savić A, Mimica N.

J Am Med Dir Assoc. 2013 May;14(5):375-6. doi: 10.1016/j.jamda.2013.01.010. Epub 2013 Feb 14.

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

Herrmann N, Gauthier S, Boneva N, Lemming OM; 10158 Investigators.

Int Psychogeriatr. 2013 Jun;25(6):919-27. doi: 10.1017/S1041610213000239. Epub 2013 Mar 8.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease

Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S.

J Alzheimers Dis. 2013;35(4):789-97. doi: 10.3233/JAD-122308.

Agitation and aggression in people with Alzheimer's disease

Ballard C, Corbett A.

Curr Opin Psychiatry. 2013 May;26(3):252-9. doi: 10.1097/YCO.0b013e32835f414b.

Benzodiazepine and dementia: a time for reflection

Bocti C, Roy-Desruisseaux J, Hudon C, Roberge P.

Maturitas. 2013 Jun;75(2):105-6. doi: 10.1016/j.maturitas.2013.03.001. Epub 2013 Mar 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias